Virtu Financial’s Mentari Therapeutics, Inc. Common Stock MTRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-1,998
Closed -$13K – 1907
2026
Q1
$13K Buy
+1,998
New +$18.8K ﹤0.01% 1440
2025
Q4
– Sell
-2,037
Closed -$45K – 1928
2025
Q3
$45K Buy
+2,037
New +$49.1K ﹤0.01% 1148
2024
Q4
– Sell
-142
Closed -$7K – 1775
2024
Q3
$7K Sell
142
-291
-67% -$14.8K ﹤0.01% 1232
2024
Q2
$23K Buy
+433
New +$24.7K ﹤0.01% 1014
2023
Q1
– Sell
-89
Closed -$36K – 1772
2022
Q4
$36K Buy
+89
New +$59.9K ﹤0.01% 1144
2021
Q4
– Sell
-2
Closed -$20K – 1928
2021
Q3
$20K Buy
+2
New +$23.8K ﹤0.01% 1382

Other funds holding MTRI

Virtu Financial's MTRI Position: Q2 2026 in Review

Virtu Financial sold out of Mentari Therapeutics, Inc. Common Stock (MTRI) in Q2 2026, closing a stake of 1,998 shares — an estimated $13K sold.

Virtu Financial first reported a position in MTRI in Q3 2021 and held it in 6 quarters. The position peaked at $45K in Q3 2025. 19 funds tracked by Wall St. Rank hold MTRI as of Q2 2026.

  • Virtu Financial reported no remaining Mentari Therapeutics, Inc. Common Stock position as of Q2 2026 after selling out during the quarter.
  • Virtu Financial sold 1,998 Mentari Therapeutics, Inc. Common Stock shares in Q2 2026, an estimated $13K.
  • Virtu Financial first reported a position in Mentari Therapeutics, Inc. Common Stock in Q3 2021 and held it in 6 quarters.
  • Virtu Financial's Mentari Therapeutics, Inc. Common Stock position peaked at $45K in Q3 2025.
  • 19 funds tracked by Wall St. Rank held Mentari Therapeutics, Inc. Common Stock as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.